Literature DB >> 7591959

Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the Eker rat model.

Y Kubo1, Y Kikuchi, H Mitani, E Kobayashi, T Kobayashi, O Hino.   

Abstract

Hereditary renal carcinomas (RCs) develop in virtually all Eker rats by the age of one year. Investigation of extra-renal primary tumors co-occurring in Eker rats late in life (at 2 years) additionally revealed enhanced development of hemangiosarcomas of the spleen, uterine leiomyosarcomas and pituitary adenomas, although the demonstrated predilection for these extra-renal tumors was not as complete as with RCs. We identified the germline mutated tuberous sclerosis (Tsc2) gene as the predisposing Eker gene and revealed the tumor suppressor nature of Tsc2 gene function in renal carcinogenesis. In the present study, we examined allelic loss at the Tsc2 gene locus in uterine leiomyosarcomas and pituitary adenomas developing in hybrid F1 rats carrying the Eker mutation as well as in pituitary adenomas from non-carrier rats. We detected loss of heterozygosity in 4 of 11 uterine leiomyosarcomas (36%) and 11 of 31 pituitary adenomas (35%) from Eker rats but in none of 9 pituitary adenomas from non-carrier rats (P < 0.05), suggesting that inactivation of the Tsc2 gene is also a critical event in the pathogenesis of these extra-renal tumors. Our present data indicate that there might be different pathways for tumorigenesis of pituitary adenomas between Eker and

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591959      PMCID: PMC5920926          DOI: 10.1111/j.1349-7006.1995.tb03092.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Lectin- and immunohistochemical studies on acquired cystic kidney and associated renal cell carcinoma.

Authors:  Y Kikuchi
Journal:  Acta Pathol Jpn       Date:  1989-06

2.  Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors.

Authors:  M Woloschak; J L Roberts; K D Post
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

3.  A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer.

Authors:  T Kobayashi; Y Hirayama; E Kobayashi; Y Kubo; O Hino
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

4.  Molecular genetic studies of sporadic pituitary tumors.

Authors:  M D Boggild; S Jenkinson; M Pistorello; M Boscaro; M Scanarini; P McTernan; C W Perrett; R V Thakker; R N Clayton
Journal:  J Clin Endocrinol Metab       Date:  1994-02       Impact factor: 5.958

5.  Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in the Eker rat.

Authors:  Y Kubo; H Mitani; O Hino
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

6.  Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.

Authors:  R S Yeung; G H Xiao; F Jin; W C Lee; J R Testa; A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

7.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

8.  A novel cancer predisposition syndrome in the Eker rat model.

Authors:  O Hino; H Mitani; H Katsuyama; Y Kubo
Journal:  Cancer Lett       Date:  1994-08-15       Impact factor: 8.679

9.  Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors:  J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance.

Authors:  N Hu; A Gutsmann; D C Herbert; A Bradley; W H Lee; E Y Lee
Journal:  Oncogene       Date:  1994-04       Impact factor: 9.867

View more
  11 in total

Review 1.  The role of progesterone signaling in the pathogenesis of uterine leiomyoma.

Authors:  J Julie Kim; Elizabeth C Sefton
Journal:  Mol Cell Endocrinol       Date:  2011-06-06       Impact factor: 4.102

2.  Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene.

Authors:  T Kobayashi; H Mitani; R Takahashi; M Hirabayashi; M Ueda; H Tamura; O Hino
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.

Authors:  H Onda; A Lueck; P W Marks; H B Warren; D J Kwiatkowski
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 4.  Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC).

Authors:  David J Kwiatkowski
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

5.  Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.

Authors:  B J Quade; A P Pinto; D R Howard; W A Peters; C P Crum
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

6.  Renal carcinogenesis in the Eker rat.

Authors:  O Hino; E Kobayashi; M Nishizawa; Y Kubo; T Kobayashi; Y Hirayama; S Takai; Y Kikuchi; H Tsuchiya; K Orimoto
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development.

Authors:  Shengli Cai; Jeffrey I Everitt; Hiroyuki Kugo; Jennifer Cook; Elena Kleymenova; Cheryl Lyn Walker
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 8.  The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth.

Authors:  Sam Amin; Andrew Lux; Finbar O'Callaghan
Journal:  Br J Clin Pharmacol       Date:  2018-11-08       Impact factor: 4.335

9.  Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3.

Authors:  Peter J Klover; Rajesh L Thangapazham; Jiro Kato; Ji-An Wang; Stasia A Anderson; Victoria Hoffmann; Wendy K Steagall; Shaowei Li; Elizabeth McCart; Neera Nathan; Joshua D Bernstock; Matthew D Wilkerson; Clifton L Dalgard; Joel Moss; Thomas N Darling
Journal:  Elife       Date:  2017-07-11       Impact factor: 8.140

10.  Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.

Authors:  Pier Selenica; Niamh Conlon; Carlene Gonzalez; Denise Frosina; Achim A Jungbluth; Regina G H Beets-Tan; Mamta K Rao; Yanming Zhang; Ryma Benayed; Marc Ladanyi; David B Solit; Sarah Chiang; David M Hyman; Martee L Hensley; Robert A Soslow; Britta Weigelt; Rajmohan Murali
Journal:  Am J Surg Pathol       Date:  2021-01       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.